5:29pm ET
Investing
Thursday’s Top 10 After-Hours Stocks on the Move
ThinkstockThursday may have been a mixed day in the markets with a gain in the S&P 500 and a drop in the Dow, but there are many stocks with big moves or…
Companies
/Healthcare
Lexicon Pharmaceuticals Inc
$2.29
▼ $0.03 (−1.29%) today
Markets closed · 2:27am ET
LXRX Coverage
Page 3
10:53am ET
Health and Healthcare
BioHealth Business Daily (ABII, STEM, XNPT, LXRX, MIPI, LLY, GTXI, SHPGY, JAZZ)
We are seeing many key movers in the BioHealth space today. Biotech stocks and drug stocks are often more volatile than other sectors. Today’s BioHealth Business Daily includes the key moves and…
7:56am ET
Investing
Public Offering Floodgates Open Wide (CUZ, DHX, DFS, EPR, FNSR, FPO, GEL, G, GLP, HIG, IRDM, LXRX, NVAX, ORG, SATC, TTMI)
If you think you are alone in noticing that the markets have held up extremely well, you better take a look and see what managers and officers of public companies are doing…
1:25pm ET
Health and Healthcare
Biophama Firms Lexicon And Poniard In The Hurt Locker
Biophama companies are horrible investments at least 90% of the time because they are gambles on the IQs of small groups of scientists and the whims of the FDA. Poniard Pharmaceuticals (PARD) and Lexicon Pharmaceuticals (LXRX)…
Douglas A. McIntyre 8:57am ET
Investing
Top Day Trader Alerts (BBY, BCRX, C, DNDN, ING, LXRX, YHOO)
These are this morning’s top pre-market day trader alert stocks. We have more color and more detail on price and volume analysis linked through to each at VSInvestor.com: Best Buy Co. (NYSE:…
8:42am ET
Health and Healthcare
Lexicon New Alzheimer’s Disease Trial Dosing (LXRX)
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) has announced that dosing has commenced in its Phase IIa clinical trial with LX6171. This is an oral drug candidate that is implied for the treatment of…
Douglas A. McIntyre 6:53am ET
Investing
Pre-Market Stock News (June 18, 2007)
(AA) An ALCOA bid from BHP may be kindled according to numerous M&A reports.(ADVNA) Advanta trades ex-split to reflect a 3-2 stock split.(AGU) Agrium said earnings will be at or above the…
3:31am ET
Health and Healthcare
Lexicon Pharmaceuticals: Back From The Depths With New Investors (LXRX)
Lexicon Pharmaceuticals, Inc. (LXRX-NASDAQ) is a biotech company that many have not heard of, and those who do know it may have a painful history from it. Anyone who got in the…
Douglas A. McIntyre